APA (7th ed.) Citation

Hatzipanagiotou, M. E., Pigerl, M., Gerken, M., Räpple, S., Zeltner, V., Hetterich, M., . . . Seitz, S. (2023). Does timing of neoadjuvant chemotherapy influence the prognosis in patients with early triple negative breast cancer? Journal of Cancer Research and Clinical Oncology, 149(13), 11941-11950. https://doi.org/10.1007/s00432-023-05060-y

Chicago Style (17th ed.) Citation

Hatzipanagiotou, Maria Eleni, et al. "Does Timing of Neoadjuvant Chemotherapy Influence the Prognosis in Patients with Early Triple Negative Breast Cancer?" Journal of Cancer Research and Clinical Oncology 149, no. 13 (2023): 11941-11950. https://doi.org/10.1007/s00432-023-05060-y.

MLA (9th ed.) Citation

Hatzipanagiotou, Maria Eleni, et al. "Does Timing of Neoadjuvant Chemotherapy Influence the Prognosis in Patients with Early Triple Negative Breast Cancer?" Journal of Cancer Research and Clinical Oncology, vol. 149, no. 13, 2023, pp. 11941-11950, https://doi.org/10.1007/s00432-023-05060-y.